Pressé, M., Malgrange, B., & Delacroix, L. (07 December 2023). The Cochlear Matrisome: Importance in Hearing and Deafness. Matrix Biology: Journal of the International Society for Matrix Biology, 125, 40 - 58. doi:10.1016/j.matbio.2023.12.002 |
Veithen, M.* , Huyghe, A.* , Van Den Ackerveken, P., Fukada, S.-I., Kokubo, H., Breuskin, I., Nguyen, L., Delacroix, L.* , & Malgrange, B.*. (25 August 2023). Sox9 Inhibits Cochlear Hair Cell Fate by Upregulating Hey1 and HeyL Antagonists of Atoh1. Cells, 12 (17), 2148. doi:10.3390/cells12172148 * These authors have contributed equally to this work. |
Pouyo, L. R., Chung, K., Delacroix, L., & Malgrange, B. (2021). The ubiquitin-proteasome system in normal hearing and deafness. Hearing Research, 108366. doi:10.1016/j.heares.2021.108366 |
Pouyo, L. R., Thelen, N., Delacroix, L., & Malgrange, B. (13 June 2019). Functions of NEDD4-2 in the auditory portion of the inner ear [Paper presentation]. BSCDB Spring meeting, June 13th, 2019, Liège, Belgium. |
Czajkowski, A., Mounier, A., Delacroix, L., & Malgrange, B. (2019). Pluripotent stem cell-derived cochlear cells: a challenge in constant progress. Cellular and Molecular Life Sciences. doi:10.1007/s00018-018-2950-5 |
Freeman, S., Mateo Sanchez, S., Delacroix, L., & Malgrange, B. (18 May 2016). Disruption of the lysine acetyltransferase Elp3 causes planar polarity defects in the mouse organ of Corti [Poster presentation]. 10th Molecular Biology of Hearing and Deafness Conference. |
Czajkowski, A., Grobarczyk, B., Hanon, K., LEFEBVRE, P., Delacroix, L., & Malgrange, B. (May 2016). Derivation of cochlear cells from pathological or isogenic human iPSCs for modeling hereditary hearing loss [Poster presentation]. 10th Molecular Biology of Hearing and Deafness conference, Hinxton, United Kingdom. |
Czajkowski, A., Chariot, A. (Other coll.), Delacroix, L. (Other coll.), & Malgrange, B. (Other coll.). (29 May 2015). Unravelling Cemip expression and functions in the auditory portion of the inner ear [Poster presentation]. BSCDB - BELGIAN SOCIETY FOR CELL AND DEVELOPMENTAL BIOLOGY. |
Huyghe, A.* , Van Den Ackerveken, P.* , SACHELI, R., Prevot, P.-P., Thelen, N., Renauld, J., Thiry, M., Delacroix, L., Nguyen, L., & Malgrange, B. (2015). MicroRNA-124 Regulates Cell Specification in the Cochlea through Modulation of Sfrp4/5. Cell Reports, 13, 31-42. doi:10.1016/j.celrep.2015.08.054 * These authors have contributed equally to this work. |
Mateo Sanchez, S., Delacroix, L., Laguesse, S., Huysseune, S., Chariot, A., Nguyen, L., & Malgrange, B. (31 May 2013). Unravelling the roles of lysine acetylation by Elp3 during inner ear development [Poster presentation]. BSN Congress. |
Tautz, L., Vang, T., Liu, W., Delacroix, L., Wu, S., Vasile, S., Dahl, R., Yang, L., MUSUMECI, L., Francis, D., Landskron, J., Tasken, K., Tremblay, M., Lie, B., Page, R., Mustelin, T., Rahmouni, S., & Rickert, R. (April 2012). Dynamic interaction between lymphoid tyrosine phosphatase and C-terminal Src kinase controls T cell activation. FASEB Journal, 26. |
Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491 |
Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760 |
Allouche, A., Nolens, G., Tancredi, A., Delacroix, L., Mardaga, J., Fridman, V., Winkler, R., Boniver, J., Delvenne, P., & Begon, D. (January 2008). The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Research, 10 (1), 9. doi:10.1186/bcr1851 |
Chatel, G., Ganeff, C., Boussif, N., Delacroix, L., Briquet, A., Nolens, G., & Winkler, R. (15 December 2007). Hedgehog signaling pathway is inactive in colorectal cancer cell lines. International Journal of Cancer, 121 (12), 2622-2627. doi:10.1002/ijc.22998 |
Begon, D., Delacroix, L., Vernimmen, D., Jackers, P., & Winkler, R. (01 July 2005). Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. Journal of Biological Chemistry, 280 (26), 24428-34. doi:10.1074/jbc.M503790200 |
Delacroix, L. (2005). Mechanisms responsible for ERBB2 gene overexpression in human breast and non-breast cancer cells. The role of AP-2 transcription factors. Cancer Therapy, 3. |
Benoit, V., Chariot, A., Delacroix, L., Deregowski, V., Jacobs, N., Merville, M.-P., & Bours, V. (2004). Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappa B through c-FLIP-L expression. Cancer Research, 64 (8), 2684-2691. doi:10.1158/0008-5472.CAN-03-2914 |